Prolonged release and c-kit expression of haemopoietic precursor cells mobilized by stem cell factor and granulocyte colony stimulating factor

British Journal of Haematology

Volumn 104, Issue 4, 1999, Pages 778-784

  Roberts, Marion M ^a,c   Swart, B W ^a,b   Simmons, P J ^a,b   Basser, R L ^d   Begley, C G ^d   To, L B ^a,b  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b HANSON INSTITUTE   (Australia)

^c Bone and Joint Research Laboratory   (Australia)

^d NONE

Author keywords

C kit expression; Mobilization; Stem cell factor

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR; STEM CELL FACTOR;

ARTICLE; CELL MATURATION; DOWN REGULATION; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033057877     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1999.01231.x     Document Type: Article

References (23)

1. Andrews, R.G., Briddell, R.A., Knitter, G.H., Opie, T., Bronsden, M., Myerson, D., Appelbaum, F.R. & McNiece, I.K. (1994) In vivo synergy between recombinant human stem cell factor and recombinant human granulocyte colony-stimulating factor in baboons: enhanced circulation of progenitor cells. Blood, 84, 800-810.
2. Andrews, R.G., Knitter, G.H., Bartelmez, S.H., Langley, K.E., Farrer, D., Hendren, W., Appelbaum, F.R., Bernstein, I.D. & Zsebo, K.M. (1991) Recombinant human stem cell factor, a c-kit ligand, stimulates hematopoiesis in primates. Blood, 78, 1975-1980.
3. Basser, R.L., To, B.L., Begley, G., Maher, D., Juttner, C.A., Cebon, J., Mansfield, R., Olver, I., Duggan, G., Szer, J., Collins, J., Swart, B., Marty, J., Menchaca, D., Sheridan, W.P., Fox, R.M. & Green, M.D. (1998) Rapid haemopoietic recovery after multiple high dose chemotherapy: enhancement of filgrastim-induced progenitor cell mobilisation by recombinant human stem cell factor. Journal of Clinical Oncology, 16, 1899-1908.
4. Begley, C.G., Basser, R., Mansfield, R., Thomson, B., Parker, W.R.L., Layton, J., To, L.B., Cebon, J., Sheridan, W.P., Fox, R.M. & Green, M.D. (1997) Enhanced levels and clonogenic capacity of blood progenitor cells following administration of SCF plus G-CSF to humans. Blood, 90, 3378-3389.
5. Chaudhary, P.M., Mechetner, E.B. & Roninson, I.B. (1992) Expression and activity of the multidrug resistance P-glycoprotein in human peripheral blood lymphocytes. Blood, 80, 2735-2739.
6. Craig, W., Kay, R., Cutler, R.L. & Lansdorp, P.M. (1993) Expression of Thy-1 on human haematopoietic progenitor cells. Journal of Experimental Medicine 177, 1331-1342.
7. Cynshi, O., Satoh, K., Shimonata, Y., Hattori, K., Nomura, H., Imai, N. & Hirashima, K. (1991) Reduced response to granulocyte colony- stimulating factor in W/Wv and SL/SLd mice. Leukaemia, 5, 75-80.
8. De Revel, T., Appelbaum, F.R., Storb, R., Schuening, F., Nash, R., Deeg, J., McNeice, I., Andrews, R. & Graham, T. (1994) Effects of granulocyte colony stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs. Blood, 83, 3795-3799.
9. Glaspy, J., LeMaistre, C.F., Lill, M., Jones, A., Moore, R., Briddell, D., Menchaca Turner, S. & Shpall, E.J. (1995) Dose-response of 7 day administration of recombinant methionyl human stem cell factor in combination with filgrastim for progenitor cell mobilisation in patients with stage II-IV breast cancer. Blood, 86, (Suppl. 1), 463a.
10. + hemopoietic progenitor cells. Blood, 85, 1936-1943.
11. Hoglund, M., Smedmyr, B., Simonsson, B., Totterman, T. & Bengtsson, M. (1996) Dose-dependent mobilisation of hematopoietic progenitor cells in healthy volunteers receiving glycosylated rHuG-CSF. Bone Marrow Transplantation, 18, 19-27.
12. + cells. Blood, 87, 949-955.
13. + hematopoietic progenitors. Blood, 88, 1168-1176.
14. Levesque, J.P., Leavesley, D.I., Niutta, S., Vadas, M. & Simmons, P.J. (1995) Cytokines increase human haemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins. Journal of Experimental Medicine, 181, 1805-1815.
15. Morrison, S.J., Wright, D.E. & Weissman, I.L. (1997) Cyclophosphamide/granulocyte colony-stimulating factor induces hematopoietic stem cells to proliferate prior to mobilisation. Proceedings of the National Academy of Sciences of the United States of America, 94, 1908-1913.
16. Moskowitz, C.H., Stiff, P., Gordon, M.S., McNiece, I., Ho, A.D., Costa, J.J., Broun. E.R., Bayer, R.A., Wyres, M., Hill, J., Jelaca- Maxwell, K., Nichols, C.R., Brown, S.L., Nimer, S.D. & Gabrilove, J. (1997) Recombinant methionyl human stem cell factor and filgrastim for peripheral blood progenitor cell mobilisation and transplantation in non-Hodgkins lymphoma patients: results of a phase I/II trial. Blood, 89, 3136-3147.
17. - subpopulation from mobilised peripheral blood. Blood, 85, 368-378.
18. Papayannopoulou, T., Priestley, G.V. & Nakamoto, B. (1998) Anti- VLA4/VCAM-1-induced mobilisation requires cooperative signaling through the kit/mkit ligand pathway. Blood, 91, 2231-2239.
19. Simmons, P.J., Leavesley, D.I., Levesque, J.P., Swart, B.W., Haylock, D.N., To, L.B., Ashman, L.K. & Juttner, C.A. (1994) The mobilisation of primitive haemopoietic progenitors into the peripheral blood: polyfunctionality of haemopoietic regulators. The Metcalf forum. Stem Cells, 12, 187-202.
20. Stiff P., Grinrich, R., Luger, S., Brown, R.A., LeMaistre, C.F., Perry, D., Schenkein, D., List, A., Mason, J.R., Bensinger, W., Wheeler, C.A., Freter, C., Murphy-Filkins, R., Wyres, M., Parker, W. & Emmanouilides, C. (1997) Improved PBPC collection using stem cell factor and filgrastim (G-CSF) compared to G-CSF alone in heavily pretreated lymphoma and Hodgkins disease patients. Blood, 90, (Suppl. 1), 591a.
21. + cells. Blood, 84, 2930-2939.
22. To, L.B., Haylock, D.N., Simmons, P.J. & Juttner, C.A. (1997) The biology and clinical uses of blood stem cells. Blood, 89, 2233-2258.
23. Weaver, A., Ryder, D., Crowther, D., Dexter, T.M. & Testa, N.G. (1996) Increased numbers of long term culture-initiating cells in the apheresis product of patients randomised to receive increasing doses of stem cell factor administered in combination with chemotherapy and a standard dose of granulocyte colony-stimulating factor. Blood, 88, 3323-3328.